Table 1.
Characteristics of the study cohort
| Diltiazem (n = 34) |
Control (n = 83) |
p | |
|---|---|---|---|
| Age (years) | 60.0 (±9.8) | 60.9 (±11.8) | 0.188 |
| Sex | 0.105 | ||
| Male | 30 (88.2) | 62 (74.7) | |
| Female | 4 (11.8) | 21 (25.3) | |
| BMI (kg/m2) | 23.8 (±3.9) | 25.2 (±4.6) | 0.124 |
| Diabetes mellitus | 4 (11.8) | 4 (4.8) | 0.177 |
| Arterial hypertension | 14 (41.2) | 28 (33.7) | 0.446 |
| Coronary heart disease | 2 (5.9) | 8 (9.6) | 0.509 |
| COPD | 4 (11.8) | 11 (13.2) | 0.827 |
| Renal insufficiency | 1 (2.9) | 1 (1.2) | 0.511 |
| Preoperative chemotherapy and/or radiotherapy | 23 (67.6) | 68 (81.9) | 0.092 |
Data are the mean ± standard deviation or number (%)
BMI body mass index, COPD chronic obstructive pulmonary disease